Vaš brskalnik ne omogoča JavaScript!
JavaScript je nujen za pravilno delovanje teh spletnih strani. Omogočite JavaScript ali pa uporabite sodobnejši brskalnik.
Repozitorij Univerze v Ljubljani
Nacionalni portal odprte znanosti
Odprta znanost
DiKUL
slv
|
eng
Iskanje
Brskanje
Novo v RUL
Kaj je RUL
V številkah
Pomoč
Prijava
Podrobno
Circularity in plastic packaging industry : PRO EMBA's sustainable business model
ID
Rahne, Liza
(
Avtor
),
ID
Rejc Buhovac, Adriana
(
Mentor
)
Več o mentorju...
URL - Predstavitvena datoteka, za dostop obiščite
http://www.cek.ef.uni-lj.si/magister/rahne4482-B.pdf
Galerija slik
Jezik:
Angleški jezik
Ključne besede:
circular economy
,
environmental protection
,
recycling
,
packaging
,
plastics
,
research
,
analysis
,
cases
Vrsta gradiva:
Magistrsko delo/naloga
Tipologija:
2.09 - Magistrsko delo
Organizacija:
EF - Ekonomska fakulteta
Kraj izida:
Ljubljana
Založnik:
[L. Rahne]
Leto izida:
2021
Št. strani:
IV, 63, 20 str.
PID:
20.500.12556/RUL-136870
UDK:
658
COBISS.SI-ID:
104506115
Datum objave v RUL:
19.06.2022
Število ogledov:
919
Število prenosov:
81
Metapodatki:
Citiraj gradivo
Navadno besedilo
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
RAHNE, Liza, 2021,
Circularity in plastic packaging industry : PRO EMBA’s sustainable business model
[na spletu]. Magistrsko delo. Ljubljana : L. Rahne. [Dostopano 30 marec 2025]. Pridobljeno s: http://www.cek.ef.uni-lj.si/magister/rahne4482-B.pdf
Kopiraj citat
Objavi na:
Sekundarni jezik
Jezik:
Slovenski jezik
Naslov:
Krožnost v panogi plastične embalaže: trajnostni poslovni model podjetja PRO EMBA
Ključne besede:
krožno gospodarstvo
,
varstvo okolja
,
recikliranje
,
embalaža
,
plastične mase
,
raziskave
,
analiza
,
primeri
Podobna dela
Podobna dela v RUL:
Systematic review and meta-analysis of observational studies evaluating treatment outcomes in patients with metastatic non-small-cell lung cancer on first-line immune checkpoint inhibitors therapy
Description of adverse event of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer treated at the University Clinic Golnik
Effectivness and safety of immunotherapy in patients with advanced non-small cell lung cancer in second line treatment at the University Clinic Golnik
Evaluation of possible pembrolizumab dosing regimen racionalisation in advanced non-small cell lung cancer
ǂThe ǂpotential of immunotherapies in the treatment of lung cancer
Podobna dela v drugih slovenskih zbirkah:
ǂThe ǂrole of immune checkpoint inhibitors in the treatment of cancer of unknown origin
Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
Febrile neutropenia and grade 3/4 neutropenia in daily practice of adjuvant chemotherapy for non-small-cell lung cancer
Advances in the therapy with immune-check point inhibitors (ICI) in non-small cell lung cancer (NSCLC) in 2022
Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy
Nazaj